The file's text, extracted by GovTribe without its formatting.
SUBJECT*
Single Photon Energy (Radiopharmaceuticals)
GENERAL INFORMATION
| CONTRACTING OFFICE’S ZIP CODE* |
| 30084 |
| SOLICITATION NUMBER* |
| 36C24724Q0608 |
| RESPONSE DATE/TIME/ZONE |
| 04-24-2024 12:00PM EASTERN TIME, NEW YORK, USA |
| ARCHIVE |
| 15 DAYS AFTER THE RESPONSE DATE |
| PRODUCT SERVICE CODE* |
| Q527 |
| CONTRACTING OFFICE ADDRESS |
| Department of Veterans Affairs |
VISN 7 Network Contracting Office LaVista Business Park - Bldg A 2008 Weems Road Tucker GA 30084
POINT OF CONTACT*
Contracting Officer Quentin Deloney Quentin.Deloney@va.gov
PLACE OF PERFORMANCE
| ADDRESS |
| Atlanta VA Health Care System |
1670 Clairmont Road
Decatur GA
COUNTRY
ADDITIONAL INFORMATION
AGENCY’S URL
URL DESCRIPTION
AGENCY CONTACT’S EMAIL ADDRESS
EMAIL DESCRIPTION
Sources Sought Notice Sources Sought Notice
DESCRIPTION
| *= Required Field |
| Sources Sought Notice |
Sources Sought Notice
THIS IS A SMALL BUSINESS SOURCES SOUGHT NOTICE REPRESENTING A MARKET SURVEY AND IS NOT A REQUEST FOR PROPOSALS, PROPOSAL ABSTRACTS, QUOTATIONS OR INVITATION FOR BIDS
The Department of Veterans Affairs is conducting a sources sought to obtain information regarding: (1) the availability and capability of qualified small business sources; (2) whether they are Service-Disabled Veteran-Owned, Veteran-Owned, Small Business, HUB Zone 8(a), Women-Owned, or small disadvantaged business concerns; and (3) their size classification relative to the North American Industry Classification System (NAICS) code for the proposed acquisition. Your responses to the information requested will assist the Government in determining the appropriate acquisition method, including whether a set-aside is possible. An organization that is not considered a small business under the applicable NAICS code should not submit a response to this notice. Small businesses concerns shall be capable of providing the necessary equipment and personnel to furnish service in the volume required for all the items under this contract. Contractor shall meet all requirements of Federal, State or City codes regarding operations of this type of service.
The NAICS code is 325412 (Size Standard: 1,300 Employees) The intent of this notice is to determine the availability of qualified commercial sources technically capable of providing the items below:
Single Photon Energy (Radiopharmaceuticals)
Strength/Packaging Packaging
Bulk Tc-99m Sodium Pertechnetate (NaO4Tc) (36,500 total mCi/yr) (calibrate 12:00 MID EST) 36,500 total mCi/yr Sat/Sun/Holiday multi-dose vial
| Tc-99m Pyrophosphate (PYP) (25mCi) |
| 25 mCi/unit dose |
| unit dose |
| Tc-99m Sodium Pertechnetate (NaO4Tc) |
| 30 mCi/unit dose |
| unit dose |
| Tc-99m Medronate (MDP) |
| 20 mCi/unit dose |
| unit dose |
| Tc-99m Technescan (HDP) |
| 20 mCi/unit dose |
| unit dose |
| Tc-99m Mertiatide (MAG3) |
| 10 mCi/unit dose |
| unit dose |
| Tc-99m Diethylenetriamine Pentaacetate (DTPA) |
| 40 mCi/unit dose |
| unit dose |
Cold vial for preparation of Tc-99m Diethylenetriamine Pentaacetate (DTPA)
Cold vial for preparation of Tc-99m Pyrophosphate (PYP)
Cold vial for preparation of Tc-99m Macro Aggregated Albumin (MAA)
Cold vial for preparation of Tc-99 Mebrofenin
| Sincalide (Kinevac) vial |
| 1 vial |
| vial |
| Tc-99m Sulfur Colloid (1 mCi) |
| 1 mCi/unit dose |
| unit dose |
| Tc-99m Sulfur Colloid (1-10 mCi) |
| 1-10 mCi/unit dose |
| unit dose |
| Tc-99m Sulfur Colloid (10-20 mCi) |
| 10-20 mCi/unit dose |
| unit dose |
| Tc-99m Sulfur Colloid (micro-filtered) |
| 50-300 uCi/unit dose |
| unit dose |
| Tc-99m Macro Aggregated Albumin (MAA) |
| 8 mCi/unit dose |
| unit dose |
| Tc-99m Mebrofenin or Disofenin |
| 8 mCi/unit dose |
| unit dose |
| Tc-99m Sestamibi (parathyroid imaging) |
| 20 mCi/unit dose |
| unit dose |
Tc-99m Sestamibi or Tetrofosmin (cardiac rest dose)
| 10 mCi/unit dose |
| unit dose |
Tc-99m Sestamibi or Tetrofosmin (cardiac stress dose)
| 30 mCi/unit dose |
| unit dose |
| T1-201 Chloride |
| 3-5 mCi/study |
| study dose |
Tc-99m Ceretec White Blood Cell (WBC) labeling (dose dependent on labeling)
| 5-30 mCi/study |
| study dose |
| Tc-99m bicisate ECD (Neurolite) |
| 10-30 mCi/ study |
| study dose |
| Tc-99m Ceretec (brain imaging) HMPAO |
| 25 mCi/unit dose |
| unit dose |
Tc-99m Succimer [Dimercaptosuccinic Acid (DMSA)]
| 5 mCi/unit dose |
| unit dose |
| I-123 NaI diagnostic capsule (100 microcurie) |
| 100 uCi/capsule |
| Individual capsule |
| I-123 NaI diagnostic capsule (200 microcurie) |
| 200 uCi/capsule |
| Individual capsule |
| I-123 NaI diagnostic capsule (4 millicurie) |
| 4 mCi [compounded in one (1) capsule] |
| Individual capsule |
I-123 Meta-Iodobenzylguanidine (MIBG) (AdreView)
| 10 mCi/unit dose |
| unit dose |
| I-123 Ioflupane (DATScan) |
| 5 mCi/vial |
| vial |
| I-123 Ioflupane (Generic) |
| 5 mCi/vial |
| vial |
| In-111 Satumomab Pendetide (Octreoscan) |
| 6 mCi/unit dose |
| unit dose |
| In-111 Pentetate (DTPA) |
| 1.5 mCi vial |
| vial |
In-111 WBC labeling (dose dependent on labeling)
| 500 uCi-1 mCi/study |
| study dose |
| Ga-67 Citrate |
| 1-8 mCi/study |
| study dose |
| NaI-131 standard calibration capsule |
| 50-100 uCi/cal cap |
| capsule |
NaI-131 diagnostic capsule (whole-body imaging)
study dose
| NaI-131 therapeutic capsule |
| 5-100 mCi/ther cap |
| capsule |
study dose
White Blood Cell (WBC) collection kit (price to include Heparin)
| Ultratag Red Blood Cell (RBC) labeling kit |
| 1 kit |
| kit |
Potential offerors having the skills, experience, professional qualifications, and capabilities necessary to perform the described requirement are invited to provide a capabilities statement via e-mail. The Capability statements shall not exceed three (3) pages and must include the following: 1) Company name and Point of Contact information (address, telephone, e-mail, web-site, etc.); 2) DUNS number and CAGE code; 3) Small Business Size/Certification (to include 8(a), HUB Zone, SDVOSB, etc.); and (4) Familiarity and product knowledge.
Responses are due no later than 1200 EST, Wednesday, April 24, 2024, and shall be electronically submitted to: quentin.deloney@va.gov. All responses will be used to determine the appropriate acquisition strategy for a potential future acquisition. Response is strictly voluntary; no reimbursement will be made for any costs associated with providing information in response to this synopsis or any follow-up information requests.
